Kura Oncology Inc (KURA)
10.06
-5.85
(-36.77%)
USD |
NASDAQ |
Nov 21, 16:00
10.04
-0.02
(-0.20%)
After-Hours: 20:00
Kura Oncology Enterprise Value: 336.48M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 336.48M |
| November 20, 2024 | 791.40M |
| November 19, 2024 | 795.29M |
| November 18, 2024 | 801.51M |
| November 15, 2024 | 792.17M |
| November 14, 2024 | 836.50M |
| November 13, 2024 | 934.48M |
| November 12, 2024 | 998.25M |
| November 11, 2024 | 919.71M |
| November 08, 2024 | 929.04M |
| November 07, 2024 | 936.04M |
| November 06, 2024 | 941.48M |
| November 05, 2024 | 916.60M |
| November 04, 2024 | 939.15M |
| November 01, 2024 | 866.58M |
| October 31, 2024 | 854.14M |
| October 30, 2024 | 873.58M |
| October 29, 2024 | 903.90M |
| October 28, 2024 | 932.66M |
| October 25, 2024 | 915.56M |
| October 24, 2024 | 936.55M |
| October 23, 2024 | 877.46M |
| October 22, 2024 | 904.68M |
| October 21, 2024 | 930.33M |
| October 18, 2024 | 953.66M |
| Date | Value |
|---|---|
| October 17, 2024 | 960.65M |
| October 16, 2024 | 974.65M |
| October 15, 2024 | 969.98M |
| October 14, 2024 | 958.32M |
| October 11, 2024 | 998.75M |
| October 10, 2024 | 972.32M |
| October 09, 2024 | 978.54M |
| October 08, 2024 | 966.10M |
| October 07, 2024 | 945.10M |
| October 04, 2024 | 956.77M |
| October 03, 2024 | 967.65M |
| October 02, 2024 | 992.53M |
| October 01, 2024 | 1.048B |
| September 30, 2024 | 1.073B |
| September 27, 2024 | 1.014B |
| September 26, 2024 | 1.009B |
| September 25, 2024 | 1.018B |
| September 24, 2024 | 1.037B |
| September 23, 2024 | 1.067B |
| September 20, 2024 | 1.123B |
| September 19, 2024 | 1.133B |
| September 18, 2024 | 1.071B |
| September 17, 2024 | 1.063B |
| September 16, 2024 | 1.117B |
| September 13, 2024 | 1.118B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
63.62M
Minimum
Mar 18 2020
2.430B
Maximum
Dec 11 2020
730.43M
Average
617.64M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.017M |
| Perspective Therapeutics Inc | -63.40M |
| Protalix BioTherapeutics Inc | 94.82M |
| Electromed Inc | 223.55M |
| Armata Pharmaceuticals Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -54.40M |
| Total Expenses (Quarterly) | 59.88M |
| EPS Diluted (Quarterly) | -0.63 |
| Earnings Yield | -23.46% |